Article
Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.
The Journal of biological chemistry - 5 Jun 2009
Lehtinen Markus J, Rops Angelique L, Isenman David E, van der Vlag Johan, Jokiranta T Sakari
Abstract excerpt
Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy associated with mutations in complement proteins, most frequently in the main plasma alternative pathway regulator factor H (FH). The hotspot for the FH mutations is in domains 19-20 (FH19-20) that are indispensable for FH activity on C3b bound covalently to host cells. In aHUS, down-regulation of cell-bound C3b by FH is impaired, but it is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
